Ranbaxy's Interview Process
Interview Process At Ranbaxy
R.P. Report
Compiled By:
Aditi
Apoorva
Nayan
Swati
Shivani
Under the Guidance of Prof. N.N.Akhouri
Ranbaxy Laboratories Limited:
Ranbaxy is one of India 's largest pharmaceutical companies. Incorporated in 1961, Ranbaxy exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. The company went public in 1973, and Japanese company Daiichi Sankyo gained majority control in 2008.
Milestones in Ranbaxy’s Path:
The year 1994 marked three distinct changes including the withdrawal of contract with Eli Lily, establishing of separate head quarters in the United Kingdom and USA and the beginning of functioning at the Gurgaon plant. By now the company had established itself in Africa, India, China, US, and UK.
In 2000, the company entered, the German markets by acquiring Bayer’s generic business.
In 2003,Ranbaxy received the prestigious The Economic Times Award for Corporate Excellence for ‘The Company of the Year, 2002-2003’.
Ranbaxy acquires Be Tabs pharmaceuticals, Terapia and acquires unbranded generic business of GSK in Spain and Italy.
In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., first by purchasing 34.8% of the total stakes followed by 64.2% in November 2008, to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 20 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing.
An interesting point to note is that throughout history, Ranbaxy has grown through Mergers and Acquisitions. This can be attributed to the increasing levels of inward FDI, the growth in the Indian economy, and relaxation of the constraints on Indian companies, which wanted to
R.P. Report
Compiled By:
Aditi
Apoorva
Nayan
Swati
Shivani
Under the Guidance of Prof. N.N.Akhouri
Ranbaxy Laboratories Limited:
Ranbaxy is one of India 's largest pharmaceutical companies. Incorporated in 1961, Ranbaxy exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. The company went public in 1973, and Japanese company Daiichi Sankyo gained majority control in 2008.
Milestones in Ranbaxy’s Path:
The year 1994 marked three distinct changes including the withdrawal of contract with Eli Lily, establishing of separate head quarters in the United Kingdom and USA and the beginning of functioning at the Gurgaon plant. By now the company had established itself in Africa, India, China, US, and UK.
In 2000, the company entered, the German markets by acquiring Bayer’s generic business.
In 2003,Ranbaxy received the prestigious The Economic Times Award for Corporate Excellence for ‘The Company of the Year, 2002-2003’.
Ranbaxy acquires Be Tabs pharmaceuticals, Terapia and acquires unbranded generic business of GSK in Spain and Italy.
In June 2008, Ranbaxy entered into an alliance with one of the largest Japanese innovator companies, Daiichi Sankyo Company Ltd., first by purchasing 34.8% of the total stakes followed by 64.2% in November 2008, to create an innovator and generic pharmaceutical powerhouse. The combined entity now ranks among the top 20 pharmaceutical companies, globally. The transformational deal will place Ranbaxy in a higher growth trajectory and it will emerge stronger in terms of its global reach and in its capabilities in drug development and manufacturing.
An interesting point to note is that throughout history, Ranbaxy has grown through Mergers and Acquisitions. This can be attributed to the increasing levels of inward FDI, the growth in the Indian economy, and relaxation of the constraints on Indian companies, which wanted to
References: 1. http://indolinkenglish.wordpress.com/2010/04/29/ranbaxy-to-step-up-head-count-launch-new-drugs 2. Arthur, Diane. Recruiting, Interviewing, Selecting & Orienting New Employees. New Delhi: Rekha Printers Private Limited, 2010. 3. http://en.wikipedia.org/wiki/Ranbaxy 4. http://www.ranbaxy.com